Wired-Gov·2 min read·medium
Landmark NHS approval of cancer drugs offers new hope for children and adults with rare blood cancers
✦AI Summary
NHS England has approved two new drug treatments for rare blood cancers, including histiocytic neoplasms and Hodgkin lymphoma. These therapies offer new options for patients who have not responded to standard treatments, with one drug allowing for home-based administration.
Infants and young children are among hundreds of patients set to receive new life-saving drugs for rare blood cancers.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in